Actinogen Medical (ASX:ACW) Share Price and News - StockTrack

Market Cap (23-May) $66,720,148 (584th)	Close (30-Jun) $0.040 0 (0%)	Volume (30-Jun) 696,012	Shortsold (16-Jan) 98 (0.00%) (641st)
52w High $0.099	52w Low $0.021	P/E 25.97	EPS 0

	Subject
	ACW ACW Ann: ACW announces open IND for Phase 2 Fragile X trial & LOI
	1 (current) 2 3
	ACW ACW Ann: Quarterly Activity Report & Appendix 4C
	ACW ACW Ann: R&D Tax Incentive Rebate received of A$1.435 million
	ACW ACW Ann: Annual Report to Shareholders
	ACW ACW Ann: Letter to Shareholders & Notice of Annual General Meeting
	ACW ACW Ann: Date of AGM and Closing Date for Director Nominations
	ACW ACW Ann: Application for quotation of securities - ACW
	ACW ACW Ann: Appendix 4G
	ACW ACW Ann: Actinogen Medical FY21 Results- Progressing the Pipeline
	ACW ACW Ann: Appendix 4E & Annual Report
	ACW ACW Ann: Actinogen completes global patent family grant
	ACW ACW Ann: Actinogen to present at ShareCafe Small Cap Webinar
	ACW ACW Ann: Quarterly Activity Report & Appendix 4C
	ACW ACW Ann: First Patient Enrolled in XanaMIA trial
	ACW ACW Ann: Actinogen receives positive Pre-IND FDA advice for FXS
	ACW ACW Ann: Clinical progress for XanaMIA trial
	ACW ACW Ann: Actinogen Ethics Committee approval for XanaMIA study
	ACW ACW Ann: Change of Share Register Notification
	ACW ACW Ann: Response to ASX Price Query
	ACW ACW Ann: Lapse of Unlisted Options
	ACW ACW Ann: Strategic Update Teleconference Transcript
	ACW ACW Ann: Strategic Update & Teleconference Call Notification
	ACW ACW Ann: Quarterly Activity Report & Appendix 4C
	ACW ACW Ann: Appendix 3Y - Dr George Morstyn
	ACW ACW Ann: Initial Director's Interest Notice
	ACW ACW Ann: Actinogen CEO assumes Managing Director position
	ACW ACW Ann: Appendix 2A
	ACW ACW Ann: Actinogen appoints Dr Steven Gourlay as CEO
	ACW ACW Ann: Appendix 4D & Half-Year Financial Statements
	ACW ACW Ann: Change in substantial holding
	ACW ACW Ann: Cleansing Notice
	ACW ACW Ann: Appendix 2A
	ACW ACW Ann: ACW raises an addtional $3.55m under a Shortfall Placement
	ACW ACW Ann: Final Director's Interest Notice
	ACW ACW Ann: Resignation of Dr Bill Ketelbey as Chief Executive Officer
	ACW ACW Ann: Expiry of Unlisted Options
	ACW ACW Ann: FDA Grants ACW Rare Paediatric Disease Designation in FXS
	ACW ACW Ann: Pause in Trading
	ACW ACW Ann: Quarterly Activity Report & Appendix 4C
	ACW ACW Ann: Review of 2020 and outlook
	ACW ACW Ann: Replacement Constitution
	ACW ACW Ann: Results of Annual General Meeting
	ACW ACW Ann: AGM Presentations
	ACW ACW Ann: Appendix 3Y x 4
	ACW ACW Ann: Appendix 2A
	ACW ACW Ann: Completion of Entitlement Offer
	ACW ACW Ann: Actinogen files new patent applications
	ACW ACW Ann: Retail Entitlement Offer-Closing Date Reminder
	ACW ACW Ann: FDA IND Update
	ACW ACW Ann: ACW to initiate XanaFX clinical trial in Fragile X syndrome

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
22-May	$0.02	14,368,476	0.00 (0.00%)
21-May	$0.02	1,993,599	0.00 (4.55%)
19-May	$0.02	3,911,869	0.00 (0.00%)
16-May	$0.02	8,934,880	0.00 (8.33%)
15-May	$0.02	203,509,652	0.00 (7.69%)
14-May	$0.03	2,955,674	0.00 (3.70%)
12-May	$0.03	423,454	0.00 (0.00%)
08-May	$0.03	416,877	+0.00 (8.00%)
07-May	$0.03	4,140,681	0.00 (7.41%)
05-May	$0.03	1,074,116	+0.00 (3.85%)
02-May	$0.03	3,575,978	0.00 (3.70%)
01-May	$0.03	1,509,861	0.00 (0.00%)
30-Apr	$0.03	3,493,096	0.00 (0.00%)
28-Apr	$0.03	3,710,881	0.00 (3.57%)
24-Apr	$0.03	2,535,597	0.00 (6.67%)
2 up, 8 down, and 5 flat days

High $0.04	Low $0.04	Trades 59	Turnover $28,759	Volume 696,012
30 June 2023 at 4:10pm

High $0.04	Low $0.04	Trades 59	Turnover $28,759	Volume 696,012
30 June 2023 at 4:10pm

Actinogen Medical Health Care

$0.040 -0.002 (-4.76%)

$0.040 -0.002 (-4.76%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices